Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis.
Mu G, Zhang H, Liu Z, Xie Q, Zhou S, Wang Z, Wang Z, Hu K, Hou J, Zhao N, Xiang Q, Cui Y.
Mu G, et al.
Eur J Clin Pharmacol. 2022 Feb;78(2):181-190. doi: 10.1007/s00228-021-03226-6. Epub 2021 Oct 15.
Eur J Clin Pharmacol. 2022.
PMID: 34651200
We aimed to compare the efficacy and safety of standard- or low-dose rivaroxaban in patients with AF through systematic review of literature with meta-analysis. METHODS: We searched PubMed, Web of Science, EMBASE, Clinical Trials.gov, the Cochrane Library, and Bayer trial …
We aimed to compare the efficacy and safety of standard- or low-dose rivaroxaban in patients with AF through systematic review of literature …